Why Sertraline Was Likely Stopped Abruptly
The most common reason for abrupt sertraline discontinuation is patient-initiated cessation due to adverse effects, perceived lack of efficacy, or inadequate patient education about discontinuation risks. 1
Primary Reasons for Abrupt Discontinuation
1. Adverse Effects
The FDA label indicates that nausea and vomiting are the most common reasons for discontinuation 1. Other intolerable side effects include:
- Gastrointestinal symptoms (diarrhea, nausea)
- Sexual dysfunction
- Dizziness and headache
- Weight changes
- Fatigue and sweating 2
Approximately 63% of patients on SSRIs experience at least one adverse effect, making tolerability a major factor in treatment discontinuation 2.
2. Perceived Lack of Efficacy
If the patient felt their symptoms weren't improving, they may have stopped the medication without consulting their provider. Non-responders typically have sertraline concentrations <25 ng/mL and may discontinue treatment prematurely 3.
3. Inadequate Patient Education
Patients who lack knowledge about discontinuation symptoms at therapy initiation are more likely to stop abruptly 4. The FDA label emphasizes that patients should be warned not to stop sertraline without first talking to their healthcare provider 1.
4. Drug Interactions or Safety Concerns
Abrupt cessation may occur if:
- The patient started an MAOI (contraindicated within 2 weeks of sertraline) 1
- Pimozide was prescribed (absolute contraindication) 1
- Significant bleeding occurred with concurrent NSAIDs/anticoagulants 1
- Serotonin syndrome developed 1
5. Pregnancy or Breastfeeding Concerns
Some patients or providers may abruptly stop sertraline upon discovering pregnancy, though this is not recommended practice 2.
Clinical Consequences of Abrupt Discontinuation
Abrupt cessation causes significantly more discontinuation symptoms than tapering (12.0 vs 5.9 DESS events) 4. The FDA label explicitly warns about discontinuation syndrome, which includes 1:
- Neurological: Dizziness, electric shock-like sensations, paresthesias, headache
- Psychiatric: Dysphoric mood, irritability, agitation, anxiety, confusion
- Physical: Nausea, sweating, lethargy, insomnia
- Cardiovascular: Orthostatic hypotension (documented case) 5
- Hormonal: Stress response activation with increased IGF-1 and heart rate 6
These symptoms typically commence within 1 week of stopping, are usually self-limiting within 3 weeks, but can be severe enough to impair function 7.
What Should Have Been Done
The FDA label and research evidence strongly recommend gradual dose reduction rather than abrupt cessation 1, 8. Proper tapering involves:
- Low-risk patients: 25-50% dose reductions every 2 weeks (e.g., 100mg → 50mg → 25mg → stop) 8
- High-risk patients (long-term use, previous withdrawal difficulty): Smaller decrements over months, potentially down to 1mg doses 8
- Monitoring: Close observation during and after tapering for withdrawal symptoms or relapse 1
Common Pitfalls
- Assuming sertraline's longer half-life prevents withdrawal: While sertraline has less withdrawal risk than paroxetine or venlafaxine, discontinuation syndrome still occurs 8, 6
- Confusing withdrawal symptoms with relapse: Withdrawal is typically immediate (within days), while relapse develops more gradually
- Not educating patients upfront: One in five patients abruptly discontinue SSRIs in clinical practice, often due to lack of knowledge 4
Immediate Management
If your patient stopped abruptly and is symptomatic: